Fortress Biotech, Inc. (FBIO) Costs and Expenses USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Fortress Biotech, Inc. quarterly/annual Costs and Expenses history and growth rate from 2018 to 2024.
  • Fortress Biotech, Inc. Costs and Expenses for the quarter ending March 31, 2024 was $49.6 M, a 30.4% decline year-over-year.
  • Fortress Biotech, Inc. Costs and Expenses for the twelve months ending March 31, 2024 was $205 M, a 26.6% decline year-over-year.
  • Fortress Biotech, Inc. annual Costs and Expenses for 2023 was $227 M, a 18.8% decline from 2022.
  • Fortress Biotech, Inc. annual Costs and Expenses for 2022 was $279 M, a 8.54% increase from 2021.
  • Fortress Biotech, Inc. annual Costs and Expenses for 2021 was $257 M, a 84% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $205 M $49.6 M -$21.7 M -30.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $227 M $39.6 M -$31.5 M -44.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $258 M $48.5 M -$18.8 M -27.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $277 M $67.5 M -$2.32 M -3.33% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $279 M $71.3 M +$101 K +0.14% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $279 M $71 M -$13 M -15.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $292 M $67.3 M -$3.75 M -5.28% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $296 M $69.8 M +$9.11 M +15% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $287 M $71.2 M +$29.6 M +71.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $257 M $84 M +$46 M +121% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $211 M $71 M +$38.5 M +118% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $173 M $60.7 M +$25.8 M +74.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $147 M $41.6 M +$7.16 M +20.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $140 M $38.1 M -$3.46 M -8.33% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 $143 M $32.5 M +$206 K +0.64% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $143 M $34.9 M +$313 K +0.91% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $143 M $34.4 M -$4.64 M -11.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $147 M $41.5 M Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-09
Q3 2019 $32.3 M -$1.07 M -3.19% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $34.5 M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $39.1 M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q3 2018 $33.4 M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.